← Leaderboards
Dennis L Panicali
Therion Biologics Corporation
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$6,991,157 · 1
By mechanism
P01$6,991,157 · 1
Top collaborators
No co-investigators on record.
Most similar at Therion Biologics Corporation
Same institution · by research overlap
- John L Sullivan$12,806,871
- Gail P Mazzara$167,178
- Mary L Horzempa$78,512
Others in their field
Top investigators on “Aids Vaccines”
- Lawrence Corey · Fred Hutchinson Cancer Center$397,672,739
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$310,476,918
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$247,048,372
- Sharon A Nachman · Johns Hopkins University$210,246,546
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$193,500,790
- Judith S. Currier · University Of California Los Angeles$187,871,648
Research focus
Aids VaccinesHuman Immunodeficiency VirusRecombinant VirusVaccine DevelopmentVector Vaccine
Grant awards (5)
COMBINED VACCINE STRATEGIES FOR THE PREVENTION OF AIDS$1,126,760
P01 · FY2003 · AI
COMBINED VACCINE STRATEGIES FOR THE PREVENTION OF AIDS$2,198,847
P01 · FY2002 · AI
COMBINED VACCINE STRATEGIES FOR THE PREVENTION OF AIDS$1,576,586
P01 · FY2001 · AI
COMBINED VACCINE STRATEGIES FOR THE PREVENTION OF AIDS$428,756
P01 · FY2001 · AI
COMBINED VACCINE STRATEGIES FOR THE PREVENTION OF AIDS$1,660,208
P01 · FY2000 · AI